Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.

Kawai T, Sachs DH, Sprangers B, Spitzer TR, Saidman SL, Zorn E, Tolkoff-Rubin N, Preffer F, Crisalli K, Gao B, Wong W, Morris H, LoCascio SA, Sayre P, Shonts B, Williams WW Jr, Smith RN, Colvin RB, Sykes M, Cosimi AB.

Am J Transplant. 2014 Jul;14(7):1599-611. doi: 10.1111/ajt.12731. Epub 2014 Jun 5.

PMID:
24903438
[PubMed - in process]
2.

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial.

Gitelman SE, Gottlieb PA, Rigby MR, Felner EI, Willi SM, Fisher LK, Moran A, Gottschalk M, Moore WV, Pinckney A, Keyes-Elstein L, Aggarwal S, Phippard D, Sayre PH, Ding L, Bluestone JA, Ehlers MR; START Study Team.

Lancet Diabetes Endocrinol. 2013 Dec;1(4):306-16. doi: 10.1016/S2213-8587(13)70065-2. Epub 2013 Aug 28.

PMID:
24622416
[PubMed - in process]
3.

Workshop report: strategies for setting occupational exposure limits for engineered nanomaterials.

Gordon SC, Butala JH, Carter JM, Elder A, Gordon T, Gray G, Sayre PG, Schulte PA, Tsai CS, West J.

Regul Toxicol Pharmacol. 2014 Apr;68(3):305-11. doi: 10.1016/j.yrtph.2014.01.005. Epub 2014 Jan 23.

PMID:
24462629
[PubMed - in process]
Free Article
4.

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH; RAVE-ITN Research Group.

N Engl J Med. 2013 Aug 1;369(5):417-27. doi: 10.1056/NEJMoa1213277.

PMID:
23902481
[PubMed - indexed for MEDLINE]
Free Article
5.

Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders.

Herold KC, Gitelman SE, Ehlers MR, Gottlieb PA, Greenbaum CJ, Hagopian W, Boyle KD, Keyes-Elstein L, Aggarwal S, Phippard D, Sayre PH, McNamara J, Bluestone JA; AbATE Study Team.

Diabetes. 2013 Nov;62(11):3766-74. doi: 10.2337/db13-0345. Epub 2013 Jul 8.

PMID:
23835333
[PubMed - indexed for MEDLINE]
Free Article
6.

Prophylactic use of sublingual allergen immunotherapy in high-risk children: a pilot study.

Holt PG, Sly PD, Sampson HA, Robinson P, Loh R, Lowenstein H, Calatroni A, Sayre P.

J Allergy Clin Immunol. 2013 Oct;132(4):991-3.e1. doi: 10.1016/j.jaci.2013.04.049. Epub 2013 Jun 12. No abstract available.

PMID:
23768574
[PubMed - indexed for MEDLINE]
7.

Long-acting parenteral nanoformulated antiretroviral therapy: interest and attitudes of HIV-infected patients.

Williams J, Sayles HR, Meza JL, Sayre P, Sandkovsky U, Gendelman HE, Flexner C, Swindells S.

Nanomedicine (Lond). 2013 Nov;8(11):1807-13. doi: 10.2217/nnm.12.214. Epub 2013 Apr 23.

PMID:
23611617
[PubMed - indexed for MEDLINE]
8.

Identifying infants at high risk of peanut allergy: the Learning Early About Peanut Allergy (LEAP) screening study.

Du Toit G, Roberts G, Sayre PH, Plaut M, Bahnson HT, Mitchell H, Radulovic S, Chan S, Fox A, Turcanu V, Lack G; Learning Early About Peanut Allergy (LEAP) Study Team.

J Allergy Clin Immunol. 2013 Jan;131(1):135-43.e1-12. doi: 10.1016/j.jaci.2012.09.015. Epub 2012 Nov 19.

PMID:
23174658
[PubMed - indexed for MEDLINE]
9.

Safety, tolerability, and pharmacokinetics of the HIV integrase inhibitor dolutegravir given twice daily with rifampin or once daily with rifabutin: results of a phase 1 study among healthy subjects.

Dooley KE, Sayre P, Borland J, Purdy E, Chen S, Song I, Peppercorn A, Everts S, Piscitelli S, Flexner C.

J Acquir Immune Defic Syndr. 2013 Jan 1;62(1):21-7. doi: 10.1097/QAI.0b013e318276cda9.

PMID:
23075918
[PubMed - indexed for MEDLINE]
10.

Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study.

Waubant E, Pelletier D, Mass M, Cohen JA, Kita M, Cross A, Bar-Or A, Vollmer T, Racke M, Stüve O, Schwid S, Goodman A, Kachuck N, Preiningerova J, Weinstock-Guttman B, Calabresi PA, Miller A, Mokhtarani M, Iklé D, Murphy S, Kopetskie H, Ding L, Rosenberg E, Spencer C, Zamvil SS; ITN STAyCIS Study Group; ITN020AI Study Management Team.

Neurology. 2012 Apr 10;78(15):1171-8. doi: 10.1212/WNL.0b013e31824f7fdd. Epub 2012 Mar 28.

PMID:
22459680
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Nanomaterial risk assessment and management experiences related to worker health under the Toxic Substances Control Act.

Sayre P, Prothero S, Alwood J.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S98-102. doi: 10.1097/JOM.0b013e31821b1bdd.

PMID:
21654427
[PubMed - indexed for MEDLINE]
12.

Meeting the common needs of a more effective and efficient testing and assessment paradigm for chemical risk management.

Dellarco V, Henry T, Sayre P, Seed J, Bradbury S.

J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):347-60. doi: 10.1080/10937404.2010.483950.

PMID:
20574907
[PubMed - indexed for MEDLINE]
13.

Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy.

Orban T, Farkas K, Jalahej H, Kis J, Treszl A, Falk B, Reijonen H, Wolfsdorf J, Ricker A, Matthews JB, Tchao N, Sayre P, Bianchine P.

J Autoimmun. 2010 Jun;34(4):408-15. doi: 10.1016/j.jaut.2009.10.005.

PMID:
19931408
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The toxicity data landscape for environmental chemicals.

Judson R, Richard A, Dix DJ, Houck K, Martin M, Kavlock R, Dellarco V, Henry T, Holderman T, Sayre P, Tan S, Carpenter T, Smith E.

Environ Health Perspect. 2009 May;117(5):685-95. doi: 10.1289/ehp.0800168. Epub 2008 Dec 22. Review.

PMID:
19479008
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years.

Herold KC, Gitelman S, Greenbaum C, Puck J, Hagopian W, Gottlieb P, Sayre P, Bianchine P, Wong E, Seyfert-Margolis V, Bourcier K, Bluestone JA; Immune Tolerance Network ITN007AI Study Group.

Clin Immunol. 2009 Aug;132(2):166-73. doi: 10.1016/j.clim.2009.04.007. Epub 2009 May 14.

PMID:
19443276
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials.

Thomas K, Sayre P.

Toxicol Sci. 2005 Oct;87(2):316-21. Epub 2005 Jul 27. Review.

PMID:
16049265
[PubMed - indexed for MEDLINE]
Free Article
17.

Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases.

Sayre PH, Finer-Moore JS, Fritz TA, Biermann D, Gates SB, MacKellar WC, Patel VF, Stroud RM.

J Mol Biol. 2001 Nov 2;313(4):813-29. Erratum in: J Mol Biol 2002 Mar 1;316(4):1005.

PMID:
11697906
[PubMed - indexed for MEDLINE]
18.

Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase.

Lackey DB, Groziak MP, Sergeeva M, Beryt M, Boyer C, Stroud RM, Sayre P, Park JW, Johnston P, Slamon D, Shepard HM, Pegram M.

Biochem Pharmacol. 2001 Jan 15;61(2):179-89.

PMID:
11163332
[PubMed - indexed for MEDLINE]
19.

Autologous stem cell transplantation for acute myeloid leukemia in first remission.

Linker CA, Ries CA, Damon LE, Sayre P, Navarro W, Rugo HS, Rubin A, Case D, Crilley P, Topolsky D, Brodsky I, Zamkoff K, Wolfe JL.

Biol Blood Marrow Transplant. 2000;6(1):50-7.

PMID:
10707999
[PubMed - indexed for MEDLINE]
20.

ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis.

Chang CH, Scott GK, Kuo WL, Xiong X, Suzdaltseva Y, Park JW, Sayre P, Erny K, Collins C, Gray JW, Benz CC.

Oncogene. 1997 Apr 3;14(13):1617-22.

PMID:
9129154
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk